Humacyte stock falls 18% on FDA delay for ATEV (NASDAQ:HUMA)
Grandbrothers Humacyte (NASDAQ:HUMA) stock fell 18% in after-hours trading Friday after the company said the FDA has informed the company…
1 Min Read
Grandbrothers Humacyte (NASDAQ:HUMA) stock fell 18% in after-hours trading Friday after the company said the FDA has informed the company…
Sign in to your account